NR3C2 and colitis: Based on the hypothesis that targeting MR could be useful for inhibiting intestinal fibrosis, we first assessed the plasma level of the MR ligand, aldosterone, the level of colon MR expression, and the aldosterone-MR target, SGK1 in the chronic DSS colitis-induced intestinal fibrosis model (Fig. 1a).